Haemonetics (HAE) Tops Q1 EPS by 32c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 +0.74%
Revenue Growth %: +5.5%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +5.5%
Financial Fact:
Net revenues: 220.25M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.05, $0.32 better than the analyst estimate of $0.73. Revenue for the quarter came in at $311.3 million versus the consensus estimate of $292.69 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Haemonetics (HAE) spreader of 500 contracts of November 115 and 130 calls as share price up 2.5%
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
